Literature DB >> 15292475

Short-term effects of gastric bypass surgery on circulating ghrelin levels.

Rosa Morínigo1, Roser Casamitjana, Violeta Moizé, Antonio M Lacy, Salvadora Delgado, Ramon Gomis, Josep Vidal.   

Abstract

OBJECTIVE: To prospectively evaluate the short-term effects of Roux-en-Y gastric bypass (RYGBP) on ghrelin secretion and its relevance on food intake and body weight changes. RESEARCH METHODS AND PROCEDURES: Ghrelin response to a standardized test meal was evaluated in eight obese patients (BMI, 43.5 to 59.1 kg/m2) before and 6 weeks after RYGBP. Ghrelin response was compared with that of an age-matched group of six normal weight individuals (BMI, 19.6 to 24.9 kg/m2).
RESULTS: Fasting serum ghrelin levels were lower in obese subjects compared with controls (p < 0.05). Meal ingestion significantly suppressed ghrelin concentration in controls (p < 0.05) and obese subjects (p < 0.05), albeit to a lesser degree in the latter group (p < 0.05). Despite a 10.3 +/- 1.5% weight loss, fasting serum ghrelin levels were paradoxically further decreased in obese subjects 6 weeks after RYGBP (p < 0.05). Moreover, at this time-point, food intake did not elicit a significant ghrelin suppression. The changes in ghrelin secretion after RYGBP correlated with changes in insulin sensitivity (p < 0.05) and caloric intake (p < 0.05). DISCUSSION: This study showed that the adaptive response of ghrelin to body weight loss was already impaired 6 weeks after RYGBP. Our study provides circumstantial evidence for the potential role of ghrelin in the negative energy balance in RYGBP-operated patients. Copyright 2004 NAASO

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292475     DOI: 10.1038/oby.2004.139

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  37 in total

Review 1.  The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity.

Authors:  Christopher N Ochner; Charlisa Gibson; Susan Carnell; Carl Dambkowski; Allan Geliebter
Journal:  Physiol Behav       Date:  2010-05-08

2.  Short-term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects.

Authors:  J Vidal; A Ibarzabal; J Nicolau; M Vidov; S Delgado; G Martinez; J Balust; R Morinigo; A Lacy
Journal:  Obes Surg       Date:  2007-08       Impact factor: 4.129

Review 3.  Gut hormones as potential new targets for appetite regulation and the treatment of obesity.

Authors:  Benjamin C T Field; Alison M Wren; Dunstan Cooke; Stephen R Bloom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 4.  Obesity, gut hormones, and bariatric surgery.

Authors:  Dimitrios J Pournaras; Carel W le Roux
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

5.  Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects.

Authors:  J Vidal; A Ibarzabal; F Romero; S Delgado; D Momblán; L Flores; A Lacy
Journal:  Obes Surg       Date:  2008-06-03       Impact factor: 4.129

6.  Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass-induced weight loss.

Authors:  J Ybarra; E Bobbioni-Harsch; G Chassot; O Huber; Ph Morel; F Assimacopoulos-Jeannet; A Golay
Journal:  Obes Surg       Date:  2008-10-31       Impact factor: 4.129

7.  Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients.

Authors:  E Pardina; M D López-Tejero; R Llamas; R Catalán; R Galard; H Allende; V Vargas; A Lecube; J M Fort; J A Baena-Fustegueras; J Peinado-Onsurbe
Journal:  Obes Surg       Date:  2009-01-27       Impact factor: 4.129

8.  Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding.

Authors:  Mousumi Bose; Sriram Machineni; Blanca Oliván; Julio Teixeira; James J McGinty; Baani Bawa; Ninan Koshy; Antonia Colarusso; Blandine Laferrère
Journal:  Obesity (Silver Spring)       Date:  2010-01-07       Impact factor: 5.002

9.  Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice.

Authors:  Alexander V Mayorov; Neri Amara; Jason Y Chang; Jason A Moss; Mark S Hixon; Diana I Ruiz; Michael M Meijler; Eric P Zorrilla; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

Review 10.  Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?

Authors:  Mousumi Bose; Blanca Oliván; Julio Teixeira; F Xavier Pi-Sunyer; Blandine Laferrère
Journal:  Obes Surg       Date:  2008-09-27       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.